Skip to content

An Open-label, Randomized, Prospective Study of the Effectiveness, Safety, and Clinical Outcomes of Stapled Anastomoses Versus Hand-Sutured Anastomoses in Patients Undergoing Gastrointestinal End to End or Side to Side Anastomoses

An Open-label, Randomized, Prospective Study of the Effectiveness, Safety, and Clinical Outcomes of Stapled Anastomoses Versus Hand-Sutured Anastomoses in Patients Undergoing Gastrointestinal End to End or Side to Side Anastomoses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00888849
Acronym
Tiger
Enrollment
280
Registered
2009-04-28
Start date
2009-04-30
Completion date
2011-02-28
Last updated
2011-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Disease, Colorectal Disease

Keywords

Stapling, hand sutured anastamosis, colorectal disease

Brief summary

This study is being conducted to compare surgical and patient outcomes across stapled (Group II) versus hand-sutured (Group I) groups.

Interventions

PROCEDURESuturing

Suturing

PROCEDUREAdvant 55 Linear Cutter/Stapler

Advant 55 Linear Cutter/Stapler

Sponsors

Ethicon Endo-Surgery
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

a. * Able to comprehend and sign or, if illiterate, leave their thumb impression on the study informed consent document * 18 years to 75 years (inclusive) * Admitted on an emergency or elective basis requiring a single gastrointestinal anastomosis * Willing to adhere to standard postoperative care, including ventilator support if required * Female subject is postmenopausal (for at least 2 years) or surgically incapable of child bearing (at least 3 months post-surgical sterilization, with appropriate documentation) * If female subject is capable of child bearing, must use an acceptable method of birth control (hormonal or IUD) for at least 3 months prior to surgery and continue use throughout the study; maintained normal menstrual pattern for the past three months and has a negative urine pregnancy test prior to day of surgical procedure * Absence of medical history of psychiatric disorders that could limit the subject's ability to understand the procedure, comply with medical, surgical, and/or behavioral recommendations.

Exclusion criteria

* Women of childbearing potential who are pregnant at the time of screening or at the time of surgery * Subject is on treatment with Corticosteroid maintenance therapy (equivalent to \> 10mg/day of Prednisone), immunosuppressive or chemotherapeutic agents within 14 days prior to enrollment; or likely to receive one of these drugs during study period * Subject has connective tissue disease, renal failure necessitating chronic hemodialysis or chronic ambulatory peritoneal dialysis as evidenced by serum creatinine of \> 3mg/dL * Subject has liver failure as evidenced by CP category C * Immunocompromised subjects (hematological malignancies, history of bone marrow transplantation, splenectomized subjects, genetic disorders such as Lupus, severe combined immunodeficiency, etc.) or a positive HIV test result * Subject has extensive disseminated malignancy and unlikely to survive for more than 3 months based on investigator judgment * Any subject that the investigator determines is not likely to be compliant during the study period * Subjects determined or suspected to engage in substance abuse, or any subject who is currently, or has in the past 6 months, undergone substance abuse therapy * The investigator feels that the primary anastomosis is not feasible due to local conditions of the bowel or subject has unstable hemodynamic status requiring stoma * Participation in any other investigational device or drug study (non survey based trial) within 30 days of enrollment.

Design outcomes

Primary

MeasureTime frame
Time of Surgery (Skin Open to Skin Close)Day 1
Time of AnastomosisTotal time (minutes) from placement of stay suture to final anastomotic staple (Group II) or final anastomotic suture (Group I)
Return to Bowel ActivityNumber of days post-surgery to appearance of peristaltic movement

Countries

India

Participant flow

Participants by arm

ArmCount
Stapling142
Suturing
4 layered hand-sutured anastomosis
138
Total280

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath47
Overall StudyLost to Follow-up12

Baseline characteristics

CharacteristicSuturingStaplingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
10 Participants18 Participants28 Participants
Age, Categorical
Between 18 and 65 years
128 Participants124 Participants252 Participants
Age Continuous43.7 years
STANDARD_DEVIATION 15.87
43.8 years
STANDARD_DEVIATION 13.81
43.8 years
STANDARD_DEVIATION 14.86
Region of Enrollment
India
138 participants142 participants280 participants
Sex: Female, Male
Female
56 Participants64 Participants120 Participants
Sex: Female, Male
Male
82 Participants78 Participants160 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
26 / 14221 / 138
serious
Total, serious adverse events
9 / 1428 / 138

Outcome results

Primary

Return to Bowel Activity

Time frame: Number of days post-surgery to appearance of peristaltic movement

ArmMeasureValue (MEAN)Dispersion
SuturingReturn to Bowel Activity4.2 daysStandard Error 0.71
StaplingReturn to Bowel Activity4.0 daysStandard Error 0.71
p-value: 0.777495% CI: [-0.2, 0.6]ANOVA
Primary

Time of Anastomosis

Time frame: Total time (minutes) from placement of stay suture to final anastomotic staple (Group II) or final anastomotic suture (Group I)

ArmMeasureValue (MEAN)Dispersion
SuturingTime of Anastomosis20.6 minutesStandard Error 1.9
StaplingTime of Anastomosis17.6 minutesStandard Error 1.9
p-value: 0.000895% CI: [1.4, 4.5]ANOVA
Primary

Time of Surgery (Skin Open to Skin Close)

Time frame: Day 1

Population: Intent-to-Treat

ArmMeasureValue (MEAN)Dispersion
SuturingTime of Surgery (Skin Open to Skin Close)168.4 minutesStandard Error 47.4
StaplingTime of Surgery (Skin Open to Skin Close)172.7 minutesStandard Error 47.4
p-value: 0.777495% CI: [-19.4, 10.9]ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026